Acquiring Company
Azurity Pharmaceuticals
Acquired Company
Covis Pharma
Description
Azurity Pharmaceuticals announces the successful completion of its acquisition of Covis Group S.à r.l., now a wholly-owned subsidiary. This strategic acquisition enhances Azurity's leadership in branded pharmaceuticals and aims to better serve overlooked patients globally. The collaboration is expected to leverage the strengths of both organizations to accelerate drug development.
FundzWatch™ Score
64
High M&A Activity
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed